1、CRS INSIGHT Prepared for Members and Committees of Congress INSIGHTINSIGHTi i Coronavirus Disease 2019 (COVID-19) Poses Challenges for the U.S. Blood Supply Jared S. Sussman Analyst in Health Policy March 13, 2020 The current Coronavirus Disease 2019 (COVID-19) outbreak may pose significant challeng
2、es for the United States blood supply. Mitigation strategies to prevent the spread of COVID-19, such as closures of schools and workplaces, have led to blood drive cancellations, resulting in a critical blood supply shortage in the Pacific Northwest (specifically, western Washington and Oregon). Sch
3、ool closures, event cancellations, and other mitigation strategies in other areas of the country may provide challenges for maintaining a sufficient blood supply. The management and distribution of the U.S. blood supply is largely coordinated by private organizations, with some oversight by the Depa
4、rtment of Health and Human Services (HHS). Congress may consider how best to address critical storages, such as through HHS or the U.S. Food and Drug Administrations (FDA) authority over blood safety and donation guidance. Industry and Blood Center Response The nations blood supply is managed by a n
